GGGiovanna de Melo Gasques

Giovanna de Melo Gasques

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Giovanna de Melo Gasques has a total of 9 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    O agravamento das doenças reumáticas pós Covid 19: uma revisão integrativa

    by Ana Gabriella Costa Curado, Gustavo Moura Bruder, Beatriz Lima da Costa, Giovanna de Melo Gasques, Isabella Ramos Cruz, Daniel Machado Moura, Tatiana Yoshida Minakami, Igor Almeida Teixeira da Silva de Figueiredo, Jonas Laerte Longen Junior, Hallamark Alvarez Lemos Portella

    Introduction: COVID-19 is a disease caused by the new coronavirus, called SARS-CoV-2, an RNA virus, which initially emerged in Wuhan, China, in December 2019. asymptomatic and severe conditions, especially in patients with previous pathologies, such as patients with rheumatologic diseases. Method: The work was carried out in the form of an integrative review of the literature, it aimed to bring together the studies and identify the possible complications that rheumatic diseases would have in patients who contract COVID-19. Results/Discurssion: In view of the current health situation, the analysis of the studies showed that both COVID-19 and rheumatic diseases present a pathogenic cytokine, among the diseases rheumatoid arthritis, lupus erythematosus and primary Sjogren's spindrome. Conclusion: The work presented difficulties during its production, the greatest difficulty was the lack of literature that addresses the subject. Therefore, patients with DRIM must be evaluated individually and dimensioned for each clinical situation, especially in situations where COVID is suspected, in these cases the rheumatologist has a fundamental role in decision-making.